Examining efficacy of "tAT-less" delivery of a peptide against the L-type calcium channel in cardiac ischemia-reperfusion injury

ACS Nano

Volumn 7, Issue 3, 2013, Pages 2212-2220

  Clemons, Tristan D ^a   Viola, Helena M ^a   House, Michael J ^a   Iyer, K Swaminathan ^a   Hool, Livia C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

ischemia reperfusion; nanoparticle; peptide delivery

Indexed keywords

ALPHA-INTERACTING DOMAINS; INTRACELLULAR CALCIUM LEVELS; ISCHEMIA REPERFUSION; ISCHEMIA-REPERFUSION INJURY; L-TYPE CALCIUM CHANNELS; LACTATE DEHYDROGENASE; PEPTIDE DELIVERY; POLYMERIC NANOPARTICLES;

CALCIUM; DRUG DELIVERY; HEALTH RISKS; HEART; NANOPARTICLES; PATHOLOGY;

PEPTIDES;

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; MAGNETITE NANOPARTICLE; PEPTIDE FRAGMENT;

ACTIVE TRANSPORT; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENETICS; GUINEA PIG; HEART MUSCLE CELL; METABOLISM; MOLECULAR GENETICS; NANOTECHNOLOGY; PROTEIN TERTIARY STRUCTURE; REPERFUSION INJURY; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; DRUG DELIVERY SYSTEMS; GUINEA PIGS; MAGNETITE NANOPARTICLES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NANOTECHNOLOGY; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY;

EID: 84875673821     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn305211f     Document Type: Article

References (40)

1. 2+ Channel Function in the Absence of Apoptosis in Ventricular Myocytes Circ. Res. 2007, 100, 1036-1044
2. 2 J. Proteome Res. 2010, 9, 1985-1994
3. Brookes, P. S.; Yoon, Y. S.; Robotham, J. L.; Anders, M. W.; Sheu, S. S. Calcium, ATP, and ROS: A Mitochondrial Love-Hate Triangle Am. J. Physiol.: Cell Physiol. 2004, 287, 817-833
4. Frey, N.; Olson, E. N. Cardiac Hypertrophy: The Good, the Bad and the Ugly Annu. Rev. Physiol. 2003, 65, 45-79
5. Pizzetti, G.; Mailhac, A.; Li Volsi, L.; Di Marco, F.; Lu, C.; Margonato, A.; Chierchia, S. L. Beneficial Effects of Diltiazem during Myocardial Reperfusion: A Randomized Trial in Acute Myocardial Infarction Ital. Heart J. 2001, 2, 757-765
6. Bestehorn, H. P.; Neumann, F. J.; Buttner, H. J.; Betz, P.; Sturzenhofecker, P.; von Hodenberg, E.; Verdun, A.; Levai, L.; Monassier, J. P.; Roskamm, H. Evaluation of the Effect of Oral Verapamil on Clinical Outcome and Angiographic Restenosis after Percutaneous Coronary Intervention: The Randomized, Double-Blind, Placebo-Controlled, Multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events after Angioplasty (VESPA) Trial J. Am. Coll. Cardiol. 2004, 43, 2160-2165
7. Wang, Q. D.; Pernow, J.; Sjoquist, P. O.; Ryden, L. Pharmacological Possibilities for Protection Against Myocardial Reperfusion Injury Cardiovasc. Res. 2002, 55, 25-37
8. Romero, M.; Sanchez, I.; Pujol, M. D. New Advances in the Field of Calcium Channel Antagonists: Cardiovascular Effects and Structure-Activity Relationships Curr. Med. Chem.: Cardiovasc. Hematol. Agents 2003, 1, 113-141
9. Chernyak, B. V. Redox Regulation of the Mitochondrial Permeability Transition Pore Biosci. Rep. 1997, 17, 293-302
10. Berridge, M. J. Calcium Microdomains: Organization and Function Cell Calcium 2006, 40, 405-412
11. McCormack, J. G.; Halestrap, A. P.; Denton, R. M. Role of Calcium Ions in Regulation of Mammalian Intramitochondrial Metabolism Physiol. Rev. 1990, 70, 391-425
12. Bandyopadhyay, D.; Chattopadhyay, A.; Ghosh, G.; Datta, A. Oxidative Stress-Induced Ischemic Heart Disease: Protection by Antioxidants Curr. Med. Chem. 2004, 11, 369-387
13. Dhalla, N. S.; Elmoselhi, A. B.; Hata, T.; Makino, N. Status of Myocardial Antioxidants in Ischemia-Reperfusion Injury Cardiovasc. Res. 2000, 47, 446-456
14. Kilgore, K. S.; Friedrichs, G. S.; Johnson, C. R.; Schasteen, C. S.; Riley, D. P.; Weiss, R. H.; Ryan, U.; Lucchesi, B. R. Protective Effects of the Sod-Mimetic Sc-52608 against Ischemia/Reperfusion Damage in the Rabbit Isolated Heart J. Mol. Cell. Cardiol. 1994, 26, 995-1006
15. Downey, J. M.; Omar, B.; Ooiwa, H.; Mccord, J. Superoxide-Dismutase Therapy for Myocardial-Ischemia Free Radical Res. Commun. 1991, 12-3, 703-720
16. Ooiwa, H.; Stanley, A.; Felaneousbylund, A. C.; Wilborn, W.; Downey, J. M. Superoxide-Dismutase Conjugated to Polyethylene-Glycol Fails to Limit Myocardial Infarct Size after 30 min Ischemia Followed by 72 h of Reperfusion in the Rabbit J. Mol. Cell. Cardiol. 1991, 23, 119-125
17. Vanhaecke, J.; Vandewerf, F.; Ronaszeki, A.; Flameng, W.; Lesaffre, E.; Degeest, H. Effect of Superoxide-Dismutase on Infarct Size and Postischemic Recovery of Myocardial-Contractility and Metabolism in Dogs J. Am. Coll. Cardiol. 1991, 18, 224-230
18. Pragnell, M.; Dewaard, M.; Mori, Y.; Tanabe, T.; Snutch, T. P.; Campbell, K. P. Calcium-Channel Beta-Subunit Binds to a Conserved Motif in the I-II Cytoplasmic Linker of the Alpha 1-Subunit Nature 1994, 368, 67-70
19. 2+ Channels Cell. Physiol. Biochem. 1999, 9, 242-269
20. 2+ Channels and the Actin-Based Cytoskeleton FASEB J. 2002, 16
21. Brooks, H.; Lebleu, B.; Vives, E. TAT Peptide-Mediated Cellular Delivery: Back to Basics Adv. Drug Delivery Rev. 2005, 57, 559-577
22. Rapoport, M.; Lorberboum-Galski, H. TAT-Based Drug Delivery System-New Directions in Protein Delivery for New Hopes? Expert Opin. Drug Delivery 2009, 6, 453-463
23. Herce, H.; Garcia, A. Molecular Dynamics Simulations Suggest a Mechanism for Translocation of the Hiv-1 TAT Peptide across Lipid Membranes Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 20805-20810
24. Lundin, P.; Johansson, H.; Guterstam, P.; Holm, T.; Hansen, M.; Langel, U.; Andaloussi, S. Distinct Uptake Routes of Cell-Penetrating Peptide Conjugates Bioconjugate Chem. 2008, 19, 2535-2542
25. Fawell, S.; Seery, J.; Daikh, Y.; Moore, C.; Chen, L. L.; Pepinsky, B.; Barsoum, J. TAT-Mediated Delivery of Heterologous Proteins into Cells Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 664-668
26. Krpetic, Z.; Saleemi, S.; Prior, I. A.; See, V.; Qureshi, R.; Brust, M. Negotiation of Intracellular Membrane Barriers by TAT-Modified Gold Nanoparticles ACS Nano 2011, 5, 5195-5201
27. de la Fuente, J.; Berry, C. Tat Peptide as an Efficient Molecule to Translocate Gold Nanoparticles into the Cell Nucleus Bioconjugate Chem. 2005, 16, 1176-1180
28. Jones, S. W.; Christison, R.; Bundell, K.; Voyce, C. J.; Brockbank, S. M.; Newham, P.; Lindsay, M. A. Characterisation of Cell-Penetrating Peptide-Mediated Peptide Delivery Br. J. Pharmacol. 2005, 145, 1093-1102
29. Gump, J. M.; Dowdy, S. F. TAT Transduction: The Molecular Mechanism and Therapeutic Prospects Trends Mol. Med. 2007, 13, 443-448
30. Evans, C. W.; Fitzgerald, M.; Clemons, T. D.; House, M. J.; Padman, B. S.; Shaw, J. A.; Saunders, M.; Harvey, A. R.; Zdyrko, B.; Luzinov, I. et al. Multimodal Analysis of PEI-Mediated Endocytosis of Nanoparticles in Neural Cells ACS Nano 2011, 5, 8640-8648
31. Harrison, J.; Bartlett, C. A.; Cowin, G.; Nicholls, P. K.; Evans, C. W.; Clemons, T. D.; Zdyrko, B.; Luzinov, I. A.; Harvey, A. R.; Iyer, K. S. et al. In Vivo Imaging and Biodistribution of Multimodal Polymeric Nanoparticles Delivered to the Optic Nerve Small 2012, 8, 1579-1589
32. Bers, D. M. Cardiac Excitation-Contraction Coupling Nature 2002, 415, 198-205
33. Hool, L. C.; Corry, B. Redox Control of Calcium Channels: From Mechanisms to Therapeutic Opportunities Antioxid. Redox Signaling 2007, 9, 409-435
34. 2+ Channel in Ventricular Myocytes J. Mol. Cell. Cardiol. 2009, 46, 1016-1026
35. 4 (M = Fe, Co, Mn) Nanoparticles J. Am. Chem. Soc. 2004, 126, 273-279
36. 2+ Channel Alpha 1 Subunit (Alpha 1C-B) by the Beta 2a Subunit: A Peptide Which Inhibits Binding of Beta to the I-II Linker of Alpha 1 Induces Functional Uncoupling Biochem. J. 2000, 348, 657-665
37. 2+ Current to Beta-Adrenergic Receptor Stimulation via a C2 Region-Containing Protein Kinase C Isoform Circ. Res. 2000, 87, 1164-1171
38. 2+ Channel Function during Acute Hypoxia Cardiovasc. Res. 2005, 67, 624-635
39. Hotta, Y.; Fujita, M.; Nakagawa, J.; Ando, H.; Takeya, K.; Ishikawa, N.; Sakakibara, J. Contribution of Cytosolic Ionic and Energetic Milieu Change to Ischemia- and Reperfusion-Induced Injury in Guinea Pig Heart: Fluorometry and Nuclear Magnetic Resonance Studies J. Cardiovasc. Pharmacol. 1998, 31, 146-156
40. Tang, H.; Viola, H. M.; Filipovska, A.; Hool, L. C. Ca(V)1.2 Calcium Channel Is Glutathionylated during Oxidative Stress in Guinea Pig and Ischemic Human Heart Free Radical Biol. Med. 2011, 51, 1501-1511